D. Tulasne

发表

ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease

Michel E. Vandenberghe, F. Pasquier, J. Hauw, 2016, EBioMedicine.

Plasmodium pseudo-Tyrosine Kinase-like binds PP1 and SERA5 and is exported to host erythrocytes

K. Cailliau, I. Guerrera, D. Tulasne, 2019, Scientific Reports.

The ETS1 transcription factor is expressed during epithelial-mesenchymal transitions in the chick embryo and is activated in scatter factor-stimulated MDCK epithelial cells.

B. Vandenbunder, C. Quéva, D. Stéhelin, 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

The Role of ITAM- and ITIM-coupled Receptors in Platelet Activation by Collagen

S. Watson, O. Berlanga, J. Frampton, 2001, Thrombosis and Haemostasis.

Caspase cleavage of viral proteins, another way for viruses to make the best of apoptosis

D. Tulasne, A. Richard, Hu Simon, 2012, Cell Death and Disease.

Thirty years of research on met receptor to move a biomarker from bench to bedside.

M. Copin, A. Furlan, D. Tulasne, 2014, Cancer research.

Loss of a Negative Feedback Loop Involving Pea3 and Cyclin D2 Is Required for Pea3-Induced Migration in Transformed Mammary Epithelial Cells

Y. De Launoit, P. Dumont, D. Tulasne, 2013, Molecular Cancer Research.

Oncogenes and Tumor Suppressors Loss of a Negative Feedback Loop Involving Pea 3 and Cyclin D 2 Is Required for Pea 3-Induced Migration in Transformed Mammary Epithelial Cells

P. Dumont, D. Tulasne, Y. Launoit, 2013 .

2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations

E. Westhof, M. Copin, A. Kulozik, 2020, Nature Communications.

Control of cell death/survival balance by the MET dependence receptor

S. Lancel, A. Furlan, L. Héliot, 2020, eLife.

Caspase Cleavages of the Lymphocyte-oriented Kinase Prevent Ezrin, Radixin, and Moesin Phosphorylation during Apoptosis*

C. Dissous, D. Tulasne, S. Shaw, 2016, The Journal of Biological Chemistry.

Involvement of RAS‐ERK Signaling in Multiple Biological Responses to HGF/SF

B. Vandenbunder, D. Tulasne, R. Paumelle, 2002, Annals of the New York Academy of Sciences.

The Fc receptor gamma-chain is necessary and sufficient to initiate signalling through glycoprotein VI in transfected cells by the snake C-type lectin, convulxin.

S. Watson, O. Berlanga, D. Tulasne, 2002, European journal of biochemistry.

Delineation of the Region in the Glycoprotein VI Tail Required for Association with the Fc Receptor γ-Chain*

S. Watson, D. Tulasne, M. Berndt, 2003, Journal of Biological Chemistry.

Caspases shutdown nonsense-mediated mRNA decay during apoptosis

A. Furlan, D. Gruenert, D. Tulasne, 2015, Cell Death and Differentiation.

The dependence receptor TrkC triggers mitochondria-dependent apoptosis upon Cobra-1 recruitment.

F. Llambi, M. Ménard, G. Ichim, 2013, Molecular cell.

Association of Fyn and Lyn with the Proline-rich Domain of Glycoprotein VI Regulates Intracellular Signaling*

S. Watson, D. Tulasne, O. Inoue, 2002, The Journal of Biological Chemistry.

Regulation of RAS in human platelets. Evidence that activation of RAS is not sufficient to lead to ERK1-2 phosphorylation.

S. Watson, D. Tulasne, T. Bori, 2002, European journal of biochemistry.

Premature termination codon readthrough in human cells occurs in novel cytoplasmic foci and requires UPF proteins

D. Gruenert, F. Lafont, E. Werkmeister, 2017, Journal of Cell Science.

Proteolytic cleavages give receptor tyrosine kinases the gift of ubiquity

B. Foveau, D. Tulasne, C. Leroy, 2009, Oncogene.

Optimized approach for the identification of highly efficient correctors of nonsense mutations in human diseases

P. Reix, S. Rebuffat, E. Adriaenssens, 2017, PloS one.

Preparation and characterization of Zonyl-coated nanodiamonds with antifouling properties.

R. Boukherroub, L. Marcon, D. Tulasne, 2011, Chemical communications.

C-terminal peptide of thrombospondin-1 induces platelet aggregation through the Fc receptor gamma-chain-associated signaling pathway and by agglutination.

S. Watson, G. Koretzky, E. Brown, 2001, Blood.

Brief report : High MET overexpression does not predict the presence of MET exon 14 splice mutations in NSCLC : results from the IFCT Predict.amm study.

M. Copin, D. Moro-Sibilot, F. Barlesi, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A Novel Viper Venom Metalloproteinase, Alborhagin, Is an Agonist at the Platelet Collagen Receptor GPVI*

S. Watson, O. Berlanga, B. Nieswandt, 2001, The Journal of Biological Chemistry.

glycoprotein VI Interaction of calmodulin with the cytoplasmic domain of platelet

S. Watson, D. Tulasne, K. Suzuki-Inoue, 2013 .

Interaction of calmodulin with the cytoplasmic domain of platelet glycoprotein VI.

S. Watson, D. Tulasne, K. Suzuki-Inoue, 2002, Blood.

Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway

B. Vandenbunder, D. Tulasne, S. Plaza, 2002, Oncogene.

GD3 Synthase Expression Enhances Proliferation and Tumor Growth of MDA-MB-231 Breast Cancer Cells through c-Met Activation

A. Tutt, A. Grigoriadis, P. Delannoy, 2010, Molecular Cancer Research.

Expression of GD3 synthase modifies ganglioside profile and increases migration of MCF-7 breast cancer cells

Y. Rombouts, Y. Guérardel, P. Delannoy, 2012 .

The ganglioside G(D2) induces the constitutive activation of c-Met in MDA-MB-231 breast cancer cells expressing the G(D3) synthase.

Y. Rombouts, Y. Guérardel, P. Delannoy, 2012, Glycobiology.

The ganglioside GD 2 induces the constitutive activation of c-Met in MDA-MB-231 breast cancer cells expressing the GD 3 synthase

Y. Rombouts, Y. Guérardel, P. Delannoy, 2012 .

When the MET receptor kicks in to resist targeted therapies

D. Tulasne, A. Cortot, Z. Kherrouche, 2021, Oncogene.

Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients

M. Copin, F. Escande, D. Tulasne, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[MET exon 14 splicing sites mutations: A new therapeutic opportunity in lung cancer].

A. Furlan, M. Wislez, D. Tulasne, 2018, Revue des maladies respiratoires.

Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers

A. Furlan, M. Wislez, D. Tulasne, 2017, Journal of the National Cancer Institute.

High-MET status in non-small cell lung tumors correlates with receptor phosphorylation but not with the serum level of soluble form.

M. Copin, M. Lesaffre, D. Tulasne, 2016, Lung cancer.

Sequential activation of ERK and repression of JNK by scatter factor/hepatocyte growth factor in madin-darby canine kidney epithelial cells.

B. Vandenbunder, J. Coll, D. Tulasne, 2000, Molecular biology of the cell.

The shadow of death on the MET tyrosine kinase receptor

B. Foveau, D. Tulasne, 2008, Cell Death and Differentiation.

Amplification of apoptosis through sequential caspase cleavage of the MET tyrosine kinase receptor

B. Foveau, D. Tulasne, C. Leroy, 2007, Cell Death and Differentiation.

Proapoptotic Function of the MET Tyrosine Kinase Receptor through Caspase Cleavage

P. Mehlen, D. Tulasne, C. Leroy, 2004, Molecular and Cellular Biology.

The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering.

B. Vandenbunder, D. Tulasne, R. Paumelle, 1999, Molecular biology of the cell.

Functional Analysis of Somatic Mutations Affecting Receptor Tyrosine Kinase Family in Metastatic Colorectal Cancer

F. Galateau-Sallé, M. Copin, S. Truant, 2019, Molecular Cancer Therapeutics.

Hypoxia leads to decreased autophosphorylation of the MET receptor but promotes its resistance to tyrosine kinase inhibitors

M. Copin, O. Melnyk, J. Bonte, 2018, Oncotarget.

HGF/SF Regulates Expression of Apoptotic Genes in MCF‐10A Human Mammary Epithelial Cells

B. Foveau, D. Tulasne, C. Villenet, 2006, Annals of the New York Academy of Sciences.

3‐phosphoinositide‐dependent protein kinase 1 (PDK1) mediates crosstalk between Src and Akt pathways in MET receptor signaling

A. Martoriati, K. Cailliau, D. Tulasne, 2021, FEBS letters.

The caspase-generated cleavage product of Ets-1 p51 and Ets-1 p27, Cp17, induces apoptosis.

M. Aumercier, D. Tulasne, S. Choul-li, 2016, Biochemical and biophysical research communications.

Tensin-4-Dependent MET Stabilization Is Essential for Survival and Proliferation in Carcinoma Cells

J. Ivaska, O. Carpén, Nicola de Franceschi, 2014, Developmental cell.

Caspase-generated fragment of the Met receptor favors apoptosis via the intrinsic pathway independently of its tyrosine kinase activity

G. Ichim, P. Mehlen, S. Tauszig-Delamasure, 2013, Cell Death and Disease.

Shedding‐Generated Met Receptor Fragments can be Routed to Either the Proteasomal or the Lysosomal Degradation Pathway

O. Melnyk, S. Giordano, B. Foveau, 2012, Traffic.

Met degradation: more than one stone to shoot a receptor down

D. Tulasne, C. Leroy, David Tulasne, 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Caspase cleavage of Ets-1 p51 generates fragments with transcriptional dominant-negative function.

M. Aumercier, G. Leprivier, D. Tulasne, 2010, The Biochemical journal.

Phosphorylation of the MET receptor on juxtamembrane tyrosine residue 1001 inhibits its caspase-dependent cleavage.

V. Villeret, B. Foveau, D. Tulasne, 2009, Cellular signalling.

Down-regulation of the met receptor tyrosine kinase by presenilin-dependent regulated intramembrane proteolysis.

K. Reiss, S. Giordano, V. Vingtdeux, 2009, Molecular biology of the cell.

Caspase cleavage of the MET receptor generates an HGF interfering fragment.

B. Foveau, D. Tulasne, C. Leroy, 2008, Biochemical and biophysical research communications.

Molecular cloning and characterisation of SmSLK, a novel Ste20-like kinase in Schistosoma mansoni.

C. Dissous, K. Cailliau, R. Pierce, 2007, International journal for parasitology.

Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation

J. Baert, B. Foveau, J. Coll, 2007, Oncogene.

Conservation of Epidermal Growth Factor Receptor Function in the Human Parasitic Helminth Schistosoma mansoni*

C. Dissous, K. Cailliau, D. Legrand, 2004, Journal of Biological Chemistry.

ETV4 transcription factor and MMP13 metalloprotease are interplaying actors of breast tumorigenesis

S. Vacher, I. Bièche, Y. De Launoit, 2018, Breast Cancer Research.

Gemcitabine‐induced epithelial‐mesenchymal transition‐like changes sustain chemoresistance of pancreatic cancer cells of mesenchymal‐like phenotype

S. Truant, F. Pruvot, G. Huet, 2019 .

The multiple paths towards MET receptor addiction in cancer

M. Copin, D. Tulasne, A. Cortot, 2018, Oncogene.

MET amplification increases the metastatic spread of EGFR-mutated NSCLC.

M. Copin, E. Werkmeister, D. Tulasne, 2018, Lung cancer.

Outcome of EGFR-mutated NSCLC patients with MET-driven resistance to EGFR tyrosine kinase inhibitors

N. Girard, J. Mazières, D. Moro-Sibilot, 2017, Oncotarget.

PEA3 transcription factors are downstream effectors of Met signaling involved in migration and invasiveness of Met‐addicted tumor cells

D. Monté, Y. De Launoit, E. Werkmeister, 2015, Molecular oncology.

2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations

E. Westhof, M. Copin, A. Kulozik, 2020, Nature Communications.

The 2,6-diaminopurine as a highly potent corrector of UGA nonsense mutations in cancers and other genetic diseases

E. Westhof, M. Copin, P. Reix, 2020 .

Orai3 calcium channel and resistance to chemotherapy in breast cancer cells: the p53 connection

P. Kischel, D. Geerts, D. Tulasne, 2018, Cell Death & Differentiation.

Alterations in the PI3K pathway drive resistance to MET inhibitors in NSCLC harboring MET exon 14 skipping mutations.

M. Copin, F. Escande, D. Tulasne, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Necrosis- and apoptosis-related Met cleavages have divergent functional consequences

M. Copin, H. Drobecq, N. Delhem, 2015, Cell Death and Disease.

OnlineFirst on November 2 , 2010 Molecular Cancer esearch Cycle , Cell Death , and Senescence Synthase Expression Enhances Proliferation and Tumor wth of MDA-MB-231 Breast Cancer Cells through R et Activation

A. Tutt, P. Delannoy, E. Adriaenssens, 2010 .

Proteolytic cleavages of MET: the divide-and-conquer strategy of a receptor tyrosine kinase

D. Tulasne, L. Duplaquet, Marie Fernandes, 2019, BMB reports.

MET receptor variant R970C favors calpain-dependent generation of a fragment promoting epithelial cell scattering

M. Lesaffre, E. Werkmeister, D. Tulasne, 2017, Oncotarget.

Preferential Localization of MET Expression at the Invasion Front and in Spreading Cells Through Air Spaces in Non–Small Cell Lung Carcinomas

M. Copin, D. Tulasne, A. Cortot, 2017, The American journal of surgical pathology.

Plasmodium pseudo-Tyrosine Kinase-like binds PP1 and SERA5 and is exported to host erythrocytes

K. Cailliau, I. Guerrera, D. Tulasne, 2019, Scientific Reports.